Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramlintide Infusion in Pediatric Diabetes
NCT00206297Phase 3Completed
- Sponsor
- Baylor College of Medicine
- Start
- Oct 2003
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3 trial of pramlintide in type 1 diabetes mellitus (T1D), sponsored by Baylor College of Medicine. Primary endpoint: Area under the curve for glucose. Started Oct 2003; status: completed.
02
Drugs
pramlintide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00206297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206297.